Wei Zhai1, Xin Jin2, Yan Gong2, Ling-Hui Qu3, Chen Zhao4, Zhao-Hui Li2. 1. Department of Ophthalmology, General Hospital of Chinese PLA, Beijing 100853, China ; School of Medicine, Nan Kai University, Tianjin 300071, China ; Key Lab of Visual Damage, and Regeneration & Restoration of Chongqing, Chongqing 400038, China. 2. Department of Ophthalmology, General Hospital of Chinese PLA, Beijing 100853, China. 3. Key Lab of Visual Damage, and Regeneration & Restoration of Chongqing, Chongqing 400038, China ; Department of Ophthalmology, No.181 Hospital of Guilin, Guilin 541000, Guangxi Zhuang Autonomous Region, China. 4. Key Lab of Visual Damage, and Regeneration & Restoration of Chongqing, Chongqing 400038, China.
Abstract
AIM: To identify the pathogenic mutations in a Chinese pedigree affected with Usher syndrome type II (USH2). METHODS: The ophthalmic examinations and audiometric tests were performed to ascertain the phenotype of the family. To detect the genetic defect, exons of 103 known RDs -associated genes including 12 Usher syndrome (USH) genes of the proband were captured and sequencing analysis was performed to exclude known genetic defects and find potential pathogenic mutations. Subsequently, candidate mutations were validated in his pedigree and 100 normal controls using polymerase chain reaction (PCR) and Sanger sequencing. RESULTS: The patient in the family occurred hearing loss (HL) and retinitis pigmentosa (RP) without vestibular dysfunction, which were consistent with standards of classification for USH2. He carried the compound heterozygous mutations, c.721 C>T and c.1969 C>T, in the MYO7A gene and the unaffected members carried only one of the two mutations. The mutations were not present in the 100 normal controls. CONCLUSION: We suggested that the compound heterozygous mutations of the MYO7A could lead to USH2, which had revealed distinguished clinical phenotypes associated with MYO7A and expanded the spectrum of clinical phenotypes of the MYO7A mutations.
AIM: To identify the pathogenic mutations in a Chinese pedigree affected with Usher syndrome type II (USH2). METHODS: The ophthalmic examinations and audiometric tests were performed to ascertain the phenotype of the family. To detect the genetic defect, exons of 103 known RDs -associated genes including 12 Usher syndrome (USH) genes of the proband were captured and sequencing analysis was performed to exclude known genetic defects and find potential pathogenic mutations. Subsequently, candidate mutations were validated in his pedigree and 100 normal controls using polymerase chain reaction (PCR) and Sanger sequencing. RESULTS: The patient in the family occurred hearing loss (HL) and retinitis pigmentosa (RP) without vestibular dysfunction, which were consistent with standards of classification for USH2. He carried the compound heterozygous mutations, c.721 C>T and c.1969 C>T, in the MYO7A gene and the unaffected members carried only one of the two mutations. The mutations were not present in the 100 normal controls. CONCLUSION: We suggested that the compound heterozygous mutations of the MYO7A could lead to USH2, which had revealed distinguished clinical phenotypes associated with MYO7A and expanded the spectrum of clinical phenotypes of the MYO7A mutations.
Authors: Morag E Shanks; Susan M Downes; Richard R Copley; Stefano Lise; John Broxholme; Karl Az Hudspith; Alexandra Kwasniewska; Wayne Il Davies; Mark W Hankins; Emily R Packham; Penny Clouston; Anneke Seller; Andrew Om Wilkie; Jenny C Taylor; Jiannis Ragoussis; Andrea H Németh Journal: Eur J Hum Genet Date: 2012-09-12 Impact factor: 4.246
Authors: S Bernal; C Medà; T Solans; C Ayuso; B Garcia-Sandoval; D Valverde; E Del Rio; M Baiget Journal: Clin Genet Date: 2005-09 Impact factor: 4.438
Authors: Mohsin Shahzad; Theru A Sivakumaran; Tanveer A Qaiser; Julie M Schultz; Zawar Hussain; Megan Flanagan; Munir A Bhinder; Diane Kissell; John H Greinwald; Shaheen N Khan; Thomas B Friedman; Kejian Zhang; Saima Riazuddin; Sheikh Riazuddin; Zubair M Ahmed Journal: Otolaryngol Head Neck Surg Date: 2013-06-14 Impact factor: 3.497
Authors: Polona Le Quesne Stabej; Zubin Saihan; Nell Rangesh; Heather B Steele-Stallard; John Ambrose; Alison Coffey; Jenny Emmerson; Elene Haralambous; Yasmin Hughes; Karen P Steel; Linda M Luxon; Andrew R Webster; Maria Bitner-Glindzicz Journal: J Med Genet Date: 2011-12-01 Impact factor: 6.318
Authors: Thomas Besnard; Gema García-García; David Baux; Christel Vaché; Valérie Faugère; Lise Larrieu; Susana Léonard; Jose M Millan; Sue Malcolm; Mireille Claustres; Anne-Françoise Roux Journal: Mol Genet Genomic Med Date: 2013-07-10 Impact factor: 2.183